Profile for Canada Patent: 3252663
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: 3252663
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Get Started Free | Oct 17, 2036 | Abbvie | RINVOQ | upadacitinib |
| ⤷ Get Started Free | Oct 17, 2036 | Abbvie | RINVOQ | upadacitinib |
| ⤷ Get Started Free | Oct 17, 2036 | Abbvie | RINVOQ | upadacitinib |
| ⤷ Get Started Free | Oct 17, 2036 | Abbvie | RINVOQ | upadacitinib |
| ⤷ Get Started Free | Oct 17, 2036 | Abbvie | RINVOQ LQ | upadacitinib |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
